We could not find any results for:
Make sure your spelling is correct or try broadening your search.
HCW Biologics Inc is a biopharmaceutical company focused on discovering and developing novel immunotherapies to lengthen the health span by disrupting the link between chronic, low-grade inflammation and age-related diseases. The company believes age-related low-grade chronic inflammation is a signi... HCW Biologics Inc is a biopharmaceutical company focused on discovering and developing novel immunotherapies to lengthen the health span by disrupting the link between chronic, low-grade inflammation and age-related diseases. The company believes age-related low-grade chronic inflammation is a significant contributing factor to several chronic diseases and conditions, such as cancer, cardiovascular disease, diabetes, neurodegenerative diseases, and autoimmune diseases. Show more
MIRAMAR, Fla., Nov. 18, 2024 (GLOBE NEWSWIRE) -- HCW Biologics Inc. (“HCWB” or “HCW Biologics”), (NASDAQ: HCWB), a U.S.-based clinical-stage biopharmaceutical company focused on discovering and...
HCW Biologics entered into License, Research and Co-Development Agreement with WY Biotech for one of its new proprietary preclinical molecules HCW Biologics to receive upfront payment of $7...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0.0501 | 12.8494485766 | 0.3899 | 0.44 | 0.32 | 397766 | 0.38140324 | CS |
4 | -0.290901 | -39.8003286355 | 0.730901 | 0.7946 | 0.32 | 632951 | 0.51823611 | CS |
12 | -0.069586 | -13.6553986962 | 0.509586 | 2.52 | 0.2761 | 9894962 | 1.20285886 | CS |
26 | -0.56 | -56 | 1 | 2.52 | 0.2761 | 4573134 | 1.2013732 | CS |
52 | -0.83 | -65.3543307087 | 1.27 | 2.52 | 0.2761 | 2330160 | 1.20181211 | CS |
156 | -2 | -81.9672131148 | 2.44 | 3.32 | 0.2761 | 796072 | 1.22407274 | CS |
260 | -7.06 | -94.1333333333 | 7.5 | 7.51 | 0.2761 | 927646 | 2.06272302 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions